Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.2748
-0.0168 (-5.76%)
At close: Feb 13, 2026, 4:00 PM EST
0.2805
+0.0057 (2.06%)
After-hours: Feb 13, 2026, 7:13 PM EST
Iterum Therapeutics Revenue
Iterum Therapeutics had revenue of $390.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $390.00K.
Revenue (ttm)
$390.00K
Revenue Growth
n/a
P/S Ratio
25.84
Revenue / Employee
$43,333
Employees
9
Market Cap
14.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionITRM News
- 1 day ago - Iterum Therapeutics Provides Business Update - GlobeNewsWire
- 3 months ago - Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Iterum Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 - GlobeNewsWire
- 4 months ago - Iterum Therapeutics to Present Data at IDWeek 2025 - GlobeNewsWire
- 6 months ago - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - GlobeNewsWire
- 6 months ago - Iterum Therapeutics plc (ITRM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Iterum Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewsWire